Chronic Urticaria and Atopic Dermatitis in the Elderly
|
|
- Maximilian Chandler
- 6 years ago
- Views:
Transcription
1 WISC December 214 Rio de Janeiro, Brazil WAO International Scientific Conference (WISC) and the XLI (41 th ) Annual Meeting of the Brazilian Association of Allergy and Immunology (ASBAI) 22-3SY Chronic Urticaria and Atopic Dermatitis in the Elderly 11: AM - 12:3 PM, Sul America, Sala B1 Chronic Urticaria and Atopic Dermatitis in the Elderly Chairpersons:Dr Ignacio J. Ansotegui, Hospital Quiron Bizkaia, Spain Dr HaeRan Lee, South Korea, Korea COI Disclosure In relation to this presentation, I declare the following, real or perceived conflicts of interest: Research support from -GlaxoSmithKline -Japan Boehringer Ingelheim -Tanabe-Mitsubishi -Shionogi -Sanofi -Kyouwahakkou-Kirin -Novartis Pharma -Shimense Healthcare Consultancy fees from -GlaxoSmithKline -Sanofi -MSD Michihiro Hide, MD, Ph.D Department of Dermatology, Hiroshima University, Japan
2 Learning Objectives: 1.To know prevalence of atopic dermatitis and urticaria in elderly populations 2. To know clinical manifestations of atopic dermatitis and urticaria in elderly patients 3. To know prognosis of chronic urticaria and type I allergy developed in elderly ages 4. To know diagnosis of angioedema in elderly patients
3 Number of patients who visited Dermatology clinic - Nationwide study in Japan 1,2 1, (total number of patients in clinics studied) Atopic dermatitis Tinea pedis Urticaria and angioedema Total Japanese population 2 Age Depicted based on data reported by Furue M, et al. J Dermatol 38: 31-32, 211
4 Surveillance of atopic dermatitis by Web questionnaire Age of the subjects 2s 2-24 Prevalence of atopic dermatitis (selfreported) in Victoria, Australia Age:2 years Sex:M:F=48: Subjects number: 1,347 Prevalence (%) (Preregistered 25 for Web research) (Preregistered for Victoria Web population research) 2 Research 15 Have you ever period:214/mar/26-28 diagnosed as 1 Have atopic 5 you dermatitis? * ever diagnosed as atopic dermatitis? * No 85.5% Plunkett A, et al. Int J Dermatol 1999, 38, Age ( Male Femake) Yes 14.5% Have you ever diagnosed as atopic dermatitis? * *The question as been validated in comparison with questionnaire by UK working group 35% 3% 25% 2% 15% 1% 5% % 6s (24.5%) 6-38% (27.7%) % 5s % 5% % % % % Suffer from AD % 4s Under medical treatment (27.%) Age (21.%) (19.4%) 3s
5 Number of patients who consulted clinic for atopic dermatitis in Japan nation wide study based on questionnaire for general population 25 (x1,) Japanese population in 27 (x1/5,) Japanese population in 212 (x1/5,) Japanese population in 21 (x1/5,) 1 5 Age group
6 Number of patients who visited Dermatology clinic - Nationwide study in Japan 1,2 (total number of patients in clinics studied) (Cambridge, UK) Urticaria and angioedema 1, Champion, et al., Br J Derm 81: , 1969 Total Japanese population 2 Age Depicted based on data reported by Furue M, et al. J Dermatol 38: 31-32, 211
7 Prevalence of CSU in age groups and sex Prevalence of patients with CSU who visited Hiroshima University outpatient clinic (n=21) Prevalence of patients with CSU who visited Hiroshima University outpatient clinic (n=21) (adjusted with Japanese population in 26) 25 Men 2 Female 25 Men 2 Female % 1 % The analysis of out patients clinic in Hiroshima University revealed the prevalence of CSU is low in elderly people.
8 Clinical manifestations of atopic dermatitis in elderly patients 1 61 y-old F 1-3 are courtesy of Dr Tanei (Tokyo Metropolitan Geriatric Hospital, Japan) 2 79 y-old M 3 61 y-old F 3 77 y-old F 4 77 y-old F Eczematous dermatitis predominantly in the face, neck, trunk, extensor and flexure site of extremities but less commonly in the antecubital and popliteal areas.
9 Clinical manifestations of atopic dermatitis in elderly patients Tanei R and Katsuoka K. J Dermatol, 28; 35: Diagnosed 16 patients as AD out of 4,1 cases of aged ( 65 years old) patients with various types of eczema and dermatitis (.39%). M:F=3:1 Eczematous dermatitis was observed predominantly in the face, neck, trunk, extensor and flexure site of extremities, but less commonly in the antecubital and popliteal areas. Total serum IgE: 8,81±13,511 IU/ml (5~53,65) Four of them were relatively low: 5, 16, 574, 714 IU/ml Skin biopsy revealed the increase of mast cells and dermal dendritic cells bearing IgE
10 Immunohistological manifestations of atopic dermatitis in elderly patients Tanei R, et al. JEADV, 213; 27: Mast cell tryptase IgE Atopic (extrinsic) dermatitis Double staining of IgE (red) and CD11c (green) Atopic dermatitis Non-atopic eczema Non-atopic (asteatotic) eczema Merge Merge IgE CD11c DAPI IgE CD11c DAPI Mast cell and IgE + cell infiltration is increased in a lichenified skin lesion of a patients with extrinsic elderly AD. Coexistence of IgE-bearing mast cells (red), dermal dendritic cells (green) and IgE-bearing dermal dendritic cells (yellow). Courtesy of Dr Tanei (Tokyo Metropolitan Geriatric Hospital, Japan)
11 Urticaria observed in elderly patients 67yr M Anaphylaxis 8yr F CSU 76yr Acute U 69yr F CSU 69yr M CSU 84yr M Mechanical U
12 Percentage of patients with CSU whose symptoms were not sufficiently suppressed by a standard dose of antihistamine in Hiroshima University Hospital (%) % <1 1-<2 2-<3 3-<4 4-<5 5-<6 6-<7 7-<8 8- Prevalence of CSU in age groups adjusted by whole Japanese population <1 1-<2 2-<3 3-<4 4-<5 5-<6 6-<7 7-<8 8- The prevalence of urticaria is low, but the population of refractory cases among age group is similar or even worse in elderly patients
13 Prognosis of patients with CSU, not sufficiently responded to a standard dose of antihistamines Remission rates (%) <16 years-old n=1 P<.5 16 years-old n=17 Remission rates (%) 1 < 6 years old (n=95) 6 years or more (n=22) Follow-up periods (months) Follow-up periods (months) The improvement rate of <6 years-old patients appears to be slightly higher, but the difference was not significant. Hiragun M, et al. Allergy 68: , 213
14 Time course of acquired type I allergy against hydrolyzed wheat antigens From to 25 to 21, approximately 46.5 million soap cakes containing hydrolyzed wheat protein have been sold in Japan and more than 2, individuals have been identified as sensitized with the wheat protein.
15 Time course of acquired type I allergy against hydrolyzed wheat antigens Remission rates (%) < 3 years old 3 years old or more **P=.67 (n=18) (n=85) Remission rates (%) 1 5 < 6 years old (n=81) 6 years old or more (n=22) P= Remission rates (%) < 5 years old (n=65) 5 years old or more (n=38) P=.292 Remission rates (%) < 65 years old (n=92) 65 years old or more(n=11) P= Months Months Type I allergy acquired in old age tends to be prolonged
16 Surveillance of atopic dermatitis by Web questionnaire 1% 9% Disease severity (POEM) 2% Steroid phobia 8% 16% 7% 6% 5% 4% mild~moderate severe most severe 12% 8% 3% 2% 4% 1% % 2~29 3~39 4~49 5~59 6~ % 2~29 3~39 4~49 5~59 6~ Atopic dermatitis in elderly patients tends to be mild and patients tend to be less steroid-phobic as compared with younger populations of the patients.
17 Clinical manifestations of atopic dermatitis in elderly patients Age of onset and association with atopic diathesis 5 n= IgE-allergic Non-IgE-allergic Data were kindly provided by Dr Tanei R (Tanei R. J Clin Med, in press) The onset of AD was at 6 years old or later in 4% of the patients at 6.
18 Classification of angioedema 1. Bradykinin mediated C1-INH deficiency/defect Normal C1-INH Positive HAE-1 HAE-2 HAE with normal C1-INH Inheritance Negative Acquired angioedema due to C1-INH deficiency/consumption Drug-induced angioedema (eg, ACEI) Non-classified angioedema 2. Mast cell mediated, normal C1-INH IgE mediated Non-IgE mediated Anaphylaxis IgE-mediated urticaria Chronic spontaneous urticaria Inducible urticarias Non-classified angioedema 3. Idiopathic, normal C1-INH, negative inheritance Non-classified angioedema Lang DM, et al. International consensus on hereditary and acquired angioedema. Ann Allergy Asthma Immunol 19: , 212
19 Angioedema may be induced and/or exacerbated by either decrease of C1-INH or ACE inhibitor Kinin system Prekallikrein HMW- Kininogen Inactivated peptides Kallikrein C1-INH C1-INH Bradykinin Kininase II (ACE) ACE inhibitor Activation Inhibition ACE inhibitor may not induce angioedema immediately after the intake of medication, but after a certain duration, such as a few days, weeks, or months. The risk of ARB cannot be totally excluded, but much lower than that of ACE inhibitor. Bradykinin receptor 2 Angioedema C1-INH activity may decrease by autoantibody against C1-INH or consumption by lymph-proliferative diseases
20 24 時間後 7-year-old male. Tongue swelling on the 5 th day of the treatment with lisinopril(1). No effect of corticosteroid and antihistamine. BP=2/9mmHg Risk factors (odds ratio): -black race (2.88) -history of drug rash (3.78) -age > 65 years (1.6) -seasonal allergies (1.79)
21 Summary 1. The prevalence of AD and urticaria in elderly populations is low at present. 2. However, elderly patients with AD may increase either by non-remittance of young adults or the increase of old age onset in future. 3. Elderly AD preserves many characteristics observed in young patients, but tends to mild and avoid eruptions in cubital and popliteal regions. 4. Populations of refractory case in CSU are the same (ca. 6%) throughout the age up to 8, but diminished in patients in 8s or older. 5. On the other hand, type I allergy obtained at old age tends to remain for longer than that in young age. 6. The risk of developing angioedema by continuous use of ACE-I is higher (odds ratio: 1.6) in >65 years old and should be avoided, especially those with HAE and/or lymphoproliferative diseases.
Angioedema. Disclosures. Question #1. Objectives. Question #3. Question #2 12/28/2015. Differentiate the various angioedema subtypes
None Disclosures Jason Knuffman, M.D. Allergy and Clinical Immunology Quincy Medical Group Unity Point Health System Quincy, IL Objectives Question #1 Differentiate the various angioedema subtypes Identify
More information2012/12/5. Principle of the management of urticaria. The efficacy of systemic steroid on urticaria depends of subtypes urticaria
6 December 2012: 13:3015:00 G.04 (HICC) The Hyderabad International Convention Centre (HICC) in Hyderabad, India WISC 2012; WAO International Scientific Conference Postgraduate Course 16: URTICARIA & ANGIOEDEMA
More informationAnaphylaxis: The Atypical Varieties
Anaphylaxis: The Atypical Varieties John Johnson, D.O., PGY-4 Allergy/Immunology Fellow University Hospitals of Cleveland Case Western Reserve University School of Medicine Disclosures: None What is Anaphylaxis?
More informationEverant.in/index.php/jmpr. Journal of Medical Practice and Review
Everant.in/index.php/jmpr Journal of Medical Practice and Review Real world Efficacy and Tolerance of Bepotastine, a new 2 nd generation antihistamine, in Pruritis and other symptoms associated with cutaneous
More informationBy the end of this lecture physicians will:
No disclosure By the end of this lecture physicians will: 1. Be able to identify patients who need immune work-up. 2. Be able to recognize the manifestation of food allergies. 3. Be knowledgeable about
More informationClinical Characteristics, Treatments, and Prognosis of Atopic Eczema in the Elderly
J. Clin. Med. 205, 4, 979-997; doi:0.3390/jcm4050979 Article OPEN ACCESS Journal of Clinical Medicine ISSN 2077-0383 www.mdpi.com/journal/jcm Clinical Characteristics, Treatments, and Prognosis of Atopic
More informationANGIOEDEMA WHAT YOU NEED TO KNOW
ANGIOEDEMA WHAT YOU NEED TO KNOW K I MBERLY HULL DO No relevant disclosures OBJECTIVES Review the etiologies of angioedema without urticaria Discuss the diagnostic approach to angioedema Discuss acute
More informationAssessing the Current Treatment of Atopic Dermatitis: Unmet Needs
Transcript Details This is a transcript of a continuing medical education (CME) activity accessible on the ReachMD network. Additional media formats for the activity and full activity details (including
More informationUpdate in the Pathogenesis of Chronic Urticaria in Adults Chair: Dr Chei-Soo (South Korea), Dr Jonathan Bernstein (US)
The 24 nd Word Allergy Congress Seoul, Korea 14 October, 2014 Workshop 3: Recent Update in Chronic Urticaria Wednesday, 14 October 2015: 13:30-15:00 13:35-13:55 Update in the Pathogenesis of Chronic Urticaria
More informationItchy, Scratchy, Red and Patchy: Derm tips for primary care. Robert Gniadecki, MD
Itchy, Scratchy, Red and Patchy: Derm tips for primary care Robert Gniadecki, MD Faculty/Presenter Disclosure Faculty: Robert Gniadecki Relationships with financial sponsors: Grants/Research Support: N/A
More information7/25/2016. Use of Epinephrine in the Community. Knowledge Amongst Paramedics. Knowledge Amongst Paramedics survey of 3479 paramedics
Recognition & Management of Anaphylaxis in the Community S. Shahzad Mustafa, MD, FAAAAI Disclosures Speaker s bureau Genentech, Teva Consultant Genentech, Teva Outline Knowledge gap Definition Pathophysiology
More informationWilliam Smith Clinical Immunology & Allergy RAH/AllergySA
William Smith Clinical Immunology & Allergy RAH/AllergySA Angioedema- the role of bradykinin, hereditary angioedema and ACE-inhibitors Chronic Urticaria- autoimmunity, mast cells, anti-ige Exercise-induced
More informationPressure Challenge Test and Histopathological Inspections for 17 Japanese cases with Clinically
Pressure Challenge Test and Histopathological Inspections for 17 Japanese cases with Clinically Diagnosed Delayed Pressure Urticaria Satoshi Morioke, Shunsuke Takahagi, Kazumasa Iwamoto, Hajime Shindo,
More informationRecognition & Management of Anaphylaxis in the Community. S. Shahzad Mustafa, MD, FAAAAI
Recognition & Management of Anaphylaxis in the Community S. Shahzad Mustafa, MD, FAAAAI Disclosures None Outline Define anaphylaxis Pathophysiology Common causes Recognition and Management Definition Acute,
More informationXolair. Xolair (omalizumab) Description
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.45.02 Subject: Xolair Page: 1 of 6 Last Review Date: March 18, 2016 Xolair Description Xolair (omalizumab)
More informationXolair. Xolair (omalizumab) Description
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.45.02 Subject: Xolair Page: 1 of 7 Last Review Date: September 15, 2016 Xolair Description Xolair (omalizumab)
More informationE-1 Role of IgE and IgE receptors in allergic airway inflammation and remodeling
E-1 Role of IgE and IgE receptors in allergic airway inflammation and remodeling Ruby Pawankar, MD, Ph.D. FRCP, FAAAAI Prof. Div of Allergy, Dept of Pediatrics Nippon Medical School Tokyo, Japan pawankar.ruby@gmail.com
More informationAnti-IgE: beyond asthma
Anti-IgE: beyond asthma Yehia El-Gamal, MD, PhD, FAAAAI Professor of Pediatrics Pediatric Allergy and Immunology Unit Children s Hospital, Ain Shams University Member, WAO Board of Directors Disclosure
More informationContact Dermatitis In Atopic Patients
Contact Dermatitis In Atopic Patients Jenny Murase, MD Palo Alto Foundation Medical Group Director of Patch Testing University of California, San Francisco Associate Clinical Professor Disclosures Consultant
More informationJapanese Guidelines for Diagnosis and Treatment of Urticaria in Comparison with Other Countries Michihiro Hide 1 and Takaaki Hiragun 1
Allergology International. 2012;61:517-527 DOI: 10.2332 allergolint.12-rai-0497 REVIEW ARTICLE Review Series: Advances in Consensus, Pathogenesis and Treatment of Urticaria and Angioedema Japanese Guidelines
More informationSporadic Antihistamine-Resistant Angioedema Potential Pathophysiological Mechanisms
Sporadic Antihistamine-Resistant Angioedema Potential Pathophysiological Mechanisms Massimo Triggiani, MD, PhD Division of Allergy and Clinical Immunology University of Salerno HAWK Consensus Meeting Gargnano,
More informationDisease-specific impairment of the quality of life in adult patients with chronic spontaneous urticaria
ORIGINAL ARTICLE Korean J Intern Med 2018;33:185-192 https://doi.org/10.3904/kjim.2015.195 Disease-specific impairment of the quality of life in adult patients with chronic spontaneous urticaria Won-Sun
More informationWhich Factors Might Enhance Safety of Immunotherapy in Your Clinic?
Which Factors Might Enhance Safety of Immunotherapy in Your Clinic? David I. Bernstein MD FAAAI Professor of Medicine and Environmental Health Division of Immunology and Allergy University of Cincinnati
More informationURTICARIA. Roundtable session
URTICARIA Roundtable session Common Referral Pitfalls All urticaria is allergic All angioedema is a prelude to anaphylaxis All peri-orbital swelling is angioedema Patch testing referrals for urticaria
More information20/11/55. Food Allergy and Atopic Dermatitis. Outline of Talk - 1. Outline of talk - 2
Food Allergy and Atopic Dermatitis Pakit Vichyanond, MD Department of Pediatrics Faculty of Medicine Siriraj Hospital Mahidol University, Bangkok, Thailand Outline of Talk - 1 Frequency of food sensitization
More informationCOMMISSIONING POLICY RECOMMENDATION TREATMENT ADVISORY GROUP Policy agreed by North Lincolnshire CCG November 2012
Drug, Treatment, Device name Omalizumab (Xolair; Novartis) COMMISSIONING POLICY RECOMMENDATION TREATMENT ADVISORY GROUP Policy agreed by North Lincolnshire CCG November 2012 Licensed indication Omalizumab
More informationTest Name Results Units Bio. Ref. Interval ALLERGY, INDIVIDUAL MARKER, BANANA, SERUM (FEIA) 0.42 kua/l
LL - LL-ROHINI (NATIONAL REFERENCE 135091547 Age 28 Years Gender Female 1/9/2017 120000AM 1/9/2017 103610AM 1/9/2017 14658M Ref By Final ALLERGY, INDIVIDUAL MARKER, BANANA, SERUM 0.42 kua/l QUANTITATIVE
More informationAllergy/Immunology Marshall University Pediatrics
Allergy/Immunology Marshall University Pediatrics Description: This is a clinical rotation about the most common chronic diseases affecting both children and adults. Residents will be introduced to allergy,
More informationPredicting Response to Omalizumab in Chronic Urticaria Based on Biomarkers
Predicting Response to Omalizumab in Chronic Urticaria Based on Biomarkers Authors: *Misbah Noshela Ghazanfar, 1 Simon Francis Thomsen 1,2 1. Department of Dermatology, Bispebjerg Hospital, Copenhagen,
More informationSkin prick testing: Guidelines for GPs
INDEX Summary Offered testing but where Allergens precautions are taken Skin prick testing Other concerns Caution Skin testing is not useful in these following conditions When skin testing is uninterpretable
More informationManagement of Senile Atopic Dermatitis in Geriatric Outpatient Clinic Dermatovenereology Department Ciptomangunkusumo Hospital in
Global Journal of Medical Research: F Diseases Volume 18 Issue 2 Version 1.0 Type: Double Blind Peer Reviewed International Research Journal Publisher: Global Journals Online ISSN: 2249-4618 & Print ISSN:
More informationSLIT: Review and Update
SLIT: Review and Update Disclosure Speaker: ISTA Pharmaceuticals Speaker: GlaxoSmithKline Allergen IT - Evidence Based Evaluation: Rescue Medications Meta-analysis Disease IT # of Patients Rescue Medication
More informationMast Cell Mediators. Updates on Chronic Urticaria 11/1/2016. Urticaria: What happens in the skin?
Urticaria: What happens in the skin? Updates on Chronic Urticaria Kent Woo, MD (USA) Allergy/Immunology Internal Medicine C A U S E MC, mast cell IgE Fc eri MC Release of Mediators Activation Vasodilation
More informationHAE disease fact sheet
[Insert organization logo and the hae day :-) logo] HAE disease fact sheet Hereditary Angioedema (HAE) is a rare, potentially life threatening inherited disorder with symptoms of severe, painful, and recurring
More informationAllergic Emergencies and Anaphylaxis. George Porfiris MD, CCFP(EM),FCFP TEGH
Allergic Emergencies and Anaphylaxis George Porfiris MD, CCFP(EM),FCFP TEGH Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document may be reproduced, copied, stored, or transmitted
More informationORIGINAL ARTICLE HIGHLIGHTS FROM THIS ISSUE
ORIGINAL ARTICLE HIGHLIGHTS FROM THIS ISSUE The Urticaria Activity Score Validity, Reliability, and Responsiveness Hawro et al 1185 What is already known about this topic? The urticaria activity score
More informationRELEVANT DISCLOSURES ATOPIC DERMATITIS / ECZEMA MANAGING ECZEMA IN INFANTS AND CHILDREN
RELEVANT DISCLOSURES MANAGING ECZEMA IN INFANTS AND CHILDREN Advisory board member - MEDA (Elidel), Speaking honoraria Bayer (Advantan) Advisory board, consultant, speaker: Pfizer, Abbvie, Janssen, Elli
More informationDo My Patient s Hives Always = Allergy? Julie Sterbank, DO Allergy & Immunology MetroHealth Medical Center
Do My Patient s Hives Always = Allergy? Julie Sterbank, DO Allergy & Immunology MetroHealth Medical Center I do not have any financial or conflicts of interest to make regarding any of the items or conditions
More informationUrticaria and Angioedema. Allergy and Immunology Awareness Program
Urticaria and Angioedema Allergy and Immunology Awareness Program 1 Urticaria and Angioedema Allergy and Immunology Awareness Program Urticaria Commonly known as hives, urticarial is an itchy rash with
More informationPath2220 INTRODUCTION TO HUMAN DISEASE ALLERGY. Dr. Erika Bosio
Path2220 INTRODUCTION TO HUMAN DISEASE ALLERGY Dr. Erika Bosio Research Fellow Centre for Clinical Research in Emergency Medicine, Harry Perkins Institute of Medical Research University of Western Australia
More informationFeed those babies some peanut products!!!
Disclosures Feed those babies some peanut products!!! No relevant disclosures Edward Brooks Case presentation 5 month old male with severe eczema starting at 3 months of age. He was breast fed exclusively
More informationHien Nguyen Reeves, MD, ABAI, ABIM Clinical instructor UBC, Kelowna, BC
Hien Nguyen Reeves, MD, ABAI, ABIM Clinical instructor UBC, Kelowna, BC Disclosures Grants/Research Support: None Speakers Bureau/Honoraria: Pfizer Canada, CME Speaker Schering-Plough Merck Pictures Dermatology
More informationA llergic disorders are common and represent an important
91 REVIEW Time trends in allergic disorders in the UK R Gupta, A Sheikh, D P Strachan, H R Anderson... See end of article for authors affiliations... Correspondence to: Ms R Gupta, Division of Community
More informationScope of Practice Allergy Skin Testing in Australia In relation to revised Medicare Benefits Schedule item numbers effective 1 November 2018
Scope of Practice Allergy Skin Testing in Australia In relation to revised Medicare Benefits Schedule item numbers effective 1 November 2018 A. Introduction The Australasian Society of Clinical Immunology
More informationDepartment of Paediatrics Clinical Guideline URTICARIA GUIDELINE BACKGROUND
Department of Paediatrics Clinical Guideline URTICARIA GUIDELINE BACKGROUND This guideline is intended for use in A&E and general paediatric OPD to assist with the management of initial presentations of
More informationItch and Swelling update: Practical Approach to Urticaria & Angioedema
Itch and Swelling update: Practical Approach to Urticaria & Angioedema Robert W Hostoffer, DO, LhD, FAAP, FACOP, FACOI, FCCP Program Director, Allergy/Immunology Fellowship Neha Sanan, DO Allergy & Immunology
More informationDiagnostic Usefulness of the Serum-Specific IgE, the Skin Prick Test and the Atopy Patch Test Compared with That of the Oral Food Challenge Test
Ann Dermatol Vol. 22, No. 4, 2010 DOI: 10.5021/ad.2010.22.4.404 ORIGINAL ARTICLE Diagnostic Usefulness of the Serum-Specific IgE, the Skin Prick Test and the Atopy Patch Test Compared with That of the
More informationThey are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:
bring together everything NICE says on a topic in an interactive flowchart. are interactive and designed to be used online. They are updated regularly as new NICE guidance is published. To view the latest
More informationGlenmark Pharmaceuticals Inc., USA; Glenmark Pharmaceuticals Ltd., India. Icahn School of Medicine at Mount Sinai, New York, NY, USA;
RESULTS FROM A RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED, EXPLORATORY, MULTICENTER STUDY OF IN ADULT PATIENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS Emma Guttman-Yassky, MD, PhD 1 ; Ana B. Pavel,
More informationHow immunology informs the design of immunotherapeutics.
How immunology informs the design of immunotherapeutics. Stephen R Durham Allergy and Clinical Immunology, Royal Brompton Hospital and Imperial College London WAO Cancun Mon Dec 5 th 2011 How immunology
More informationImmunology of Asthma. Kenneth J. Goodrum,Ph. Ph.D. Ohio University College of Osteopathic Medicine
Immunology of Asthma Kenneth J. Goodrum,Ph Ph.D. Ohio University College of Osteopathic Medicine Outline! Consensus characteristics! Allergens:role in asthma! Immune/inflammatory basis! Genetic basis!
More informationREFERRAL GUIDELINES - SUMMARY
Clinical Immunology & Allergy Unit LEEDS TEACHING HOSPITALS NHS TRUST REFERRAL GUIDELINES - SUMMARY THESE GUIDELINES ARE DESIGNED TO ENSURE THAT PATIENTS REQUIRING SECONDARY CARE ARE SEEN EFFICIENTLY AND
More informationEPIPEN INSERVICE Emergency Administration of Epinephrine for the Basic EMT. Michael J. Calice MD, FACEP St. Mary Mercy Hospital
EPIPEN INSERVICE Emergency Administration of Epinephrine for the Basic EMT Michael J. Calice MD, FACEP St. Mary Mercy Hospital Case #1 NR is an 8 yo male c/o hot mouth and stomach ache after eating jelly
More informationManaging urticaria in primary care
Managing urticaria in primary care Tidman MJ. Managing urticaria in primary care. Practitioner 2015;259(1779)25-28 Dr Michael J. Tidman MD FRCP (Ed) FRCP (Lond) Consultant Dermatologist, Department of
More informationThe proposal is to add text/statements in red and to delete text/statements with strikethrough: POLICY
Omalizumab DESCRIPTION Omalizumab is a recombinant DNA-derived humanized IgG1κ monoclonal antibody which selectively binds to immunoglobulin E (IgE). High serum levels of IgE are found in individuals with
More informationThe importance of early complementary feeding in the development of oral tolerance: Concerns and controversies
The importance of early complementary feeding in the development of oral tolerance: Concerns and controversies Prescott SL, Smith P, Tang M, Palmer DJ, Sinn J, Huntley SJ, Cormack B. Heine RG. Gibson RA,
More informationTransfusion and Allergy: What is it, and what is it not? Prof. Olivier GARRAUD INTS, Paris Université de Lyon/Saint-Etienne France
Transfusion and Allergy: What is it, and what is it not? Prof. Olivier GARRAUD INTS, Paris Université de Lyon/Saint-Etienne France The commonest picture of Allergy Allergy is commonly sensed as an Antibody
More informationManagement of Chronic Idiopathic Urticaria
9/3/216 Management of Chronic Idiopathic Urticaria Brian Berman, M.D., Ph.D. Professor Emeritus of Dermatology and Dermatologic Surgery, University of Miami Co-Director Center for Clinical and Cosmetic
More informationKDIGO Conference San Francisco March KDIGO. Mechanisms of drug hypersensitivity. A. J. Bircher Dermatology/Allergology
Conference San Francisco March 27 30 2014 Mechanisms of drug hypersensitivity A. J. Bircher Dermatology/Allergology University Hospital Basel Switzerland andreas.bircher@unibas.ch Disclosure of Interests
More informationMore than Skin Deep! Chronic Spontaneous Urticaria and Hereditary Angioedema Dr Jeanette Holtzhausen
More than Skin Deep! Chronic Spontaneous Urticaria and Hereditary Angioedema Dr Jeanette Holtzhausen University of Cape Town Lung Institute Allergy diagnostic and Clinical Research Unit and Lung Clinical
More informationOmalizumab: what benefits should we expect?
ejd150659 INVESTIGATIVE REPORT Omalizumab: what benefits should we expect? Ana GIMÉNEZ-ARNAU 1 Manel VELASCO 2 Jose Carlos ARMARIO HITA 3 Moises LABRADOR-HORRILLO 4 Juan Francisco SILVESTRE SALVADOR 5
More informationDirection for Future Actions From dermatologists standpoint
Research and Reviews Direction for Future Actions From dermatologists standpoint JMAJ 52(3): 168 172, 29 Akira HATTORI,* 1 Masutaka FURUE,* 2 Michihiro HIDE,* 3 Masahiko IWAI,* 4 Shusho OKADA* 5 Abstract
More informationThe Journal of Angioedemasit amet
Hereditary Angioedema with Normal C1 Inhibitor Response to Progesterone Therapy: A Case Report and Review of the Literature. James Kuhlen MD 1,2, Ami Mehra MD 3, and Michelle Conroy MD 1, 2 1 Massachusetts
More informationU N I V E R S I T Ä T S M E D I Z I N B E R L I N
U N I V E R S I T Ä T S M E D I Z I N B E R L I N Disclosure of Significant Relationships with Commercial Companies and Organizations Funding of Research by Deutsche Forschungsgemeinschaft (DFG), EU (FP7,
More informationAllergic versus Contact
Allergic versus Contact Dermatitis Julie Sterbank, DO Assistant Clinical Professor Allergy/Immunology MetroHealth Medical Center/Case Western Reserve University Disclosure I have no financial disclosures
More information2/10/2017 THE NUTS AND BOLTS OF FOOD ALLERGY LEARNING OBJECTIVES DEFINITIONS
THE NUTS AND BOLTS OF FOOD ALLERGY Amanda Hess, MMS, PA-C San Tan Allergy & Asthma Arizona Allergy & Immunology Research Gilbert, Arizona LEARNING OBJECTIVES 1. Discuss the epidemiology, natural history
More informationFoundations in Microbiology Seventh Edition
Lecture PowerPoint to accompany Foundations in Microbiology Seventh Edition Talaro Chapter 16 To run the animations you must be in Slideshow View. Use the buttons on the animation to play, pause, and turn
More informationA llergic disorders are common and represent an important
Thorax tx38844 Module 1 11/8/06 15:15:19 Topics: 196 Thorax Online First, published on September 1, 2006 as 10.1136/thx.2004.038844 1 EPIDEMIOLOGY Time trends in allergic disorders in the UK R Gupta, A
More informationSouthern Derbyshire Shared Care Pathology Guidelines. Allergy Testing in Adults
Southern Derbyshire Shared Care Pathology Guidelines Allergy Testing in Adults Allergy Tests are not diagnostic of Allergy Purpose of Guideline How to obtain an allergy-focussed clinical history When allergy
More informationAnaphylaxis. Emergencies for the general physician. Shuaib Nasser Consultant in Allergy and Asthma Cambridge University Hospitals NHS Foundation Trust
Anaphylaxis Emergencies for the general physician Shuaib Nasser Consultant in Allergy and Asthma Cambridge University Hospitals NHS Foundation Trust Definition- Anaphylaxis A potentially life-threatening
More informationCase Report. Mechanisms of Anaphylaxis. Case Report. Case Report 37 y/o WF Is this anaphylaxis? What would you do at this point?
Mechanisms of Anaphylaxis Richard F. Lockey, M.D. Division of Allergy and Immunology Department of Internal Medicine University of South Florida Morsani College of Medicine and James A. Haley Veterans
More informationAngioedema with acquired/sporadic C1 INH deficiency. Andrea Zanichelli, Milan (Italy) Jonathan Bernstein, Cincinnati (USA)
Angioedema with acquired/sporadic C1 INH deficiency Andrea Zanichelli, Milan (Italy) Jonathan Bernstein, Cincinnati (USA) Outline Definition Systematic Literature Search Prevalence Pathophysiology Case
More informationPharmacy Medical Policy IgE Receptor Binding Inhibitors
Pharmacy Medical Policy IgE Receptor Binding Inhibitors Table of Contents Policy: Commercial Policy History Endnotes Policy: Medicare Information Pertaining to All Policies Forms Coding Information References
More informationTakhzyro (lanadelumab-flyo)
Takhzyro (lanadelumab-flyo) Policy Number: 5.01.675 Last Review: 1/2019 Origination: 1/2019 Next Review: 1/2020 Policy Blue Cross and Blue Shield of Kansas City (Blue KC) will provide coverage for Takhzyro
More informationUpdates in Food Allergy
Updates in Food Allergy Ebrahim Shakir MD Disclosures None 1 OUTLINE ADVERSE REACTIONS TO FOODS? Conflation of terms What is food allergy? ALLERGY Sensitization Gel/Coombs Type I IgE mediated Immediate
More informationcontact activation in formation diseases 67 endothelial cells and kinin formation 73 processing and degradation 68 70
Subject Index Adenosine, mast cell activation modulation 60 Age, risk factor 17, 18 Allergen elicitors 9, 10 insects, see Insect venom-induced microarrays for 136 overview of characteristics 23 recognition
More informationAllergy Medicine James MacLean, M.D.
Allergy Medicine 2018 James MacLean, M.D. Conflict of Interest Disclosures James A MacLean, MD FACAAI, FAAAAI None Objectives Identify the major causes of acute and chronic urticaria and angioedema Review
More informationSuplatast Tacrolimus Combination Therapy for Refractory Facial Erythema in Adult Patients with Atopic Dermatitis A Meta-Analysis Study
Allergology International. 27;56:269-275 DOI:.2332allergolint.O-6-478 ORIGINAL ARTICLE Suplatast Combination Therapy for Refractory Facial Erythema in Adult Patients with Atopic DermatitisA Meta-Analysis
More informationComparative efficacy of topical mometasone furoate 0.1% cream vs topical tacrolimus 0.03% ointment in the treatment of atopic dermatitis
Original Article Comparative efficacy of topical mometasone furoate 0.1% cream vs topical tacrolimus 0.03% ointment in the treatment of atopic dermatitis Md Alauddin Khan *, Lubna Khondker **, Dilshad
More informationxx Xolair 150 MG SOLR (GENENTECH)
Omalizumab NDC CODE(S) 50242-0040-xx Xolair 150 MG SOLR (GENENTECH) DESCRIPTION Omalizumab is a recombinant DNA-derived humanized IgG1κ monoclonal antibody which selectively binds to immunoglobulin E (IgE).
More informationThe management of chronic urticaria in primary care for adults and children
The management of chronic urticaria in primary care for adults and children September Version 2.0 This supersedes version 1.0 Review due in September 2019 Document location DOCUMENT CONTROL Copies of this
More informationUrticaria. Appearance. Epidemiology [1] Aetiology [2]
Page 1 of 5 View this article online at: patient.info/doctor/urticaria-pro Urticaria Urticaria, otherwise known as hives, is an itchy red blotchy rash resulting from swelling of the superficial part of
More informationFOOD ALLERGY. Dr Colin J Lumsden. Senior Lecturer and Honorary Consultant Paediatrician. Royal Preston Hospital
FOOD ALLERGY Dr Colin J Lumsden Senior Lecturer and Honorary Consultant Paediatrician Royal Preston Hospital LEARNING OUTCOMES Pathophysiology Presentation Diagnosis Investigation Management Milk Allergy
More informationFood Allergies. (Demkin). That is approximately two million kids. That number only represents children, but
McCurry!1 Bailey McCurry Kennon Biology I Honors 1 May 2018 Food Allergies Food allergies are becoming more common in today s society. More people have allergies than you might think. Research says that
More informationDNA vaccine, peripheral T-cell tolerance modulation 185
Subject Index Airway hyperresponsiveness (AHR) animal models 41 43 asthma inhibition 45 overview 41 mast cell modulation of T-cells 62 64 respiratory tolerance 40, 41 Tregs inhibition role 44 respiratory
More informationNATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE. Single Technology Appraisal (STA)
Thank you for agreeing to give us a statement on your organisation s view of the technology and the way it should be used in the NHS. Healthcare professionals can provide a unique perspective on the technology
More informationExercise-Induced Bronchoconstriction (EIB) and Asthma (EIA) in the General Population and Asthmatic Subjects
Exercise-Induced Bronchoconstriction (EIB) and Asthma (EIA) in the General Population and Asthmatic Subjects Satoshi Honjo Department of Paediatrics National Hospital Organization Fukuoka National Hospital
More informationFive things to know about anaphylaxis
Five things to know about anaphylaxis Magdalena Berger, MD FRCPC Allergist and Clinical Immunologist New Brunswick Internal Medicine Update April 22, 2016 Disclosures None relevant to this presentation
More informationAllergy Skin Prick Testing
Allergy Skin Prick Testing What is allergy? The term allergy is often applied erroneously to a variety of symptoms induced by exposure to a wide range of environmental or ingested agents. True allergy
More informationUNDERSTANDING ATOPIC DERMATITIS IN ITALY
UNDERSTANDING ATOPIC DERMATITIS IN Key points: Around 17% of people in Italy would have atopic dermatitis (AD) at some point in their life known as lifetime prevalence ; the disease is highly prevalent
More informationDepartment of Dermatology, Fukuoka National Hospital, National Hospital Organization, Yakatabaru, Minami-ku, Fukuoka , Japan 2
International Scholarly Research Network ISRN Dermatology Volume 2012, Article ID 218538, 5 pages doi:10.5402/2012/218538 Clinical Study The Relationship between Symptom Flare of Atopic Dermatitis and
More informationProceedings of the 36th World Small Animal Veterinary Congress WSAVA
www.ivis.org Proceedings of the 36th World Small Animal Veterinary Congress WSAVA Oct. 14-17, 2011 Jeju, Korea Next Congress: Reprinted in IVIS with the permission of WSAVA http://www.ivis.org 14(Fri)
More informationLifting the Veil on a Potentially Fatal Disease. May 28, Grand Hyatt New York New York, NY. Educational partner, RMEI, LLC
ANGIOEDEMA: Lifting the Veil on a Potentially Fatal Disease May 28, 2014 Grand Hyatt New York New York, NY Educational partner, RMEI, LLC Session 2: Rare Cases in Angioedema: Lifting the Veil onn a Potentially
More informationAnaphylaxis Angioedema Transplantation & graft rejection
Anaphylaxis Angioedema Transplantation & graft rejection 1 Learning objectives 1.Anaphylaxis: definition, causes, C/P, Ix, Rx 2.Angioedema: definition, causes, C/P, IX,RX 3.Transplantation & graft rejection:
More informationomalizumab 150mg solution for injection (Xolair ) SMC No. (1017/14) Novartis Pharmaceuticals UK Ltd
omalizumab 150mg solution for injection (Xolair ) SMC No. (1017/14) Novartis Pharmaceuticals UK Ltd 05 December 2014 The Scottish Medicines Consortium (SMC) has completed its assessment of the above product
More informationUNIVERSITY OF ZAGREB SCHOOL OF MEDICINE. Plan of the course. Basics of Pediatric Allergy. Academic year 2015/2016. Mirjana Turkalj
UNIVERSITY OF ZAGREB SCHOOL OF MEDICINE Plan of the course Basics of Pediatric Allergy Academic year 2015/2016 I. COURSE AIMS COURSE OUTLINE The specialty of allergy involves the management of a wide range
More informationDrug allergy and Skin Disorders. Timothy Craig, DO, FACOI Professor of Medicine and Pediatrics Distinguished Educator Penn State University, Hershey
Drug allergy and Skin Disorders Timothy Craig, DO, FACOI Professor of Medicine and Pediatrics Distinguished Educator Penn State University, Hershey The best screening test for anaphylaxis is? A. histamine
More informationMedical Policy An independent licensee of the Blue Cross Blue Shield Association
Hereditary Angioedema Page 1 of 17 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: Hereditary Angioedema (Berinert, Cinryze, Firazyr, Haegarda, Kalbitor, Ruconest,
More informationIdiopathic Anaphylaxis. Paul A. Greenberger, MD, FAAAAI 2/28/2014 Course # 1605
Idiopathic Anaphylaxis Paul A. Greenberger, MD, FAAAAI 2/28/2014 Course # 1605 Objectives Review definition and classification of idiopathic anaphylaxis Consider the differential diagnosis Critique lab
More information